早孕期筛查联合早期预防性使用阿司匹林对早发型子痫前期高危女性的成本效益
该研究基于加拿大一年387 516例活产的理论人群,用决策树分析模拟早孕期筛查联合16周前使用低剂量阿司匹林与现行实践的成本效益。
要点
- 早孕期筛查联合早期阿司匹林可减少早发型子痫前期病例并节省费用。
- 模拟加拿大387 516例活产,筛查组705例 vs 现行实践1801例。
核心结论
- 实施早孕期子痫前期筛查并对早发型子痫前期高危女性早期使用阿司匹林,可能预防大量早发型子痫前期病例,并为加拿大医疗系统带来可观费用节省。
研究设计与样本
- 基于加拿大一年387 516例活产的理论人群进行决策分析,模拟早孕期筛查联合早期(<16周)使用低剂量阿司匹林与现行实践,并比较临床与财务影响。
主要发现
- 在每年387 516例活产中,基于早孕期筛查和阿司匹林使用的早发型子痫前期估计患病数为705例,基于现行实践为1801例。
关键数值与推荐
- 早孕期筛查采用胎儿医学基金会(Fetal Medicine Foundation)算法预测早发型子痫前期风险。
- 高危女性在<16周开始使用低剂量阿司匹林。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Pre-eclampsia (PE) remains a leading cause of maternal and fetal morbidity and mortality. A first-trimester screening algorithm predicting the risk of early-onset PE has been developed and validated. Early prediction coupled with initiation of aspirin at 11-13 weeks in women identified as high risk is effective at reducing the prevalence of early-onset PE. The aim of this study was to evaluate the cost-effectiveness of this first-trimester screening program coupled with early use of low-dose aspirin in women at high risk of developing early-onset PE, in comparison to current practice in Canada. METHODS: A decision analysis was performed based on a theoretical population of 387 516 live births in Canada in 1 year. The clinical and financial impact of early preventative screening using the Fetal Medicine Foundation algorithm for prediction of early-onset PE coupled with early (< 16 weeks) use of low-dose aspirin in those at high risk was simulated and compared with current practice using decision-tree analysis. The probabilities at each decision point and associated costs of utilized resources were calculated based on published literature and public databases. RESULTS: Of the theoretical 387 516 births per year, the estimated prevalence of early PE based on first-trimester screening and aspirin use was 705 vs 1801 cases based on the current practice. This was associated with an estimated total cost of C$9.52 million with the first-trimester screening program compared with C$23.91 million with current practice for the diagnosis and management of women with early-onset PE. This equals an annual cost saving to the Canadian healthcare system of approximately C$14.39 million. CONCLUSIONS: The implementation of a first-trimester screening program for PE and early intervention with aspirin in women identified as high risk for early PE has the potential to prevent a significant number of early-onset PE cases with a substantial associated cost saving to the healthcare system in Canada. Copyright © 2018 ISUOG. Published by John Wiley & Sons Ltd.
引用
- Ortved D, Hawkins TL, Johnson JA, et al. Cost-effectiveness of first-trimester screening with early preventative use of aspirin in women at high risk of early-onset pre-eclampsia. Ultrasound Obstet Gynecol. 2019. PMID: 29700870. doi:10.1002/uog.19076
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。